IP Library Granted Patent US 9,556,442
Granted Patent B2
US 9,556,442 · App. 14/364,322 · Granted Jan 31, 2017

Attenuated and adapted strain of pseudomonas for delivering antigens

Inventors: Audrey Le Gouellec (Uriage, FR); Bertrand Toussaint (Saint Egreve, FR); Benoît Polack (Saint Martin le Vinoux, FR)
Assignees: UNIVERSITE GRENOBLE ALPES; CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE
C12N15/78A61K39/0011C07K14/435C12N1/20C12N1/36C12R1/38A61K2039/522A61K2039/523
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,556,442
App. No.
14/364,322
Granted
Jan 31, 2017
Kind
B2
Abstract

A process for obtaining an adapted strain of Pseudomonas includes the following steps: deleting the genes ExoS, ExoT, aroA and IasI in an initial Pseudomonas strain cultivated in a LB medium; progressively cultivating this strain in a chemically defined medium based on a glucose minimal medium supplemented with magnesium and calcium; wherein the adapted strain presents the same toxicity and secretion capacities than the initial strain, and its doubling time when cultivated in the chemically defined medium is less than 60 minutes. An adapted strain is furthermore treated to become ‘killed but metabolically active’.

Claims (9)

1. An adapted strain of Pseudomonas , the adapted strain of Pseudomonas having deletions of ExoS, ExoT, aroA, and IasI genes and a doubling time when cultivated in a chemically defined medium comprising magnesium and calcium of less than 60 minutes, wherein the adapted strain of Pseudomonas has been deposited at the National Collection of Microorganisms Cultures (CNCM; Institut Pasteur) under the filing number I-4564.

2. A process for obtaining the adapted strain of Pseudomonas according to claim 1 , comprising:

deleting genes ExoS, ExoT, aroA and IasI in an initial Pseudomonas strain cultivated in a LB medium;

progressively changing the culture medium from LB medium to a chemically defined medium comprising magnesium and calcium; and

selecting the adapted strains presenting a doubling time inferior to 60 minutes when cultivated in the chemically defined medium.

3. The process according to claim 2 , wherein the chemically defined medium has the following composition: a glucose minimal medium M9 supplemented with 1 mM Mg 2+ and 1 mM Ca 2+ .

4. The process according to claim 2 , wherein the adapted strain is furthermore treated to become ‘killed but metabolically active’.

5. An immunogenic composition comprising the adapted strain of Pseudomonas according to claim 1 .

6. A composition for inducing an immune response in a host, the composition comprising the adapted strain of Pseudomonas according to claim 1 .

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Dec 19, 2016
From: UNIVERSITE JOSEPH FOURIER - GRENOBLE 1; UNIVERSITE GRENOBLE ALPES
To: UNIVERSITE GRENOBLE ALPES
Reel/Frame 041062/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2014
From: LE GOUELLEC, AUDREY; TOUSSAINT, BERTRAND; POLACK, BENOIT
To: UNIVERSITE JOSEPH FOURIER - GRENOBLE 1; CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE
Reel/Frame 033368/0770 →
Continuity (1)
Related Publication 20140335125A1 · Nov 13, 2014